Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-90.68	5.05	-54.18
Graham Fair Price	169.48	95.52	35.45
PEG	-99.92	< 0.005	2.30
Price/Book	-28.59	1.11	1.55
Price/Cash Flow	-48.83	12.31	-24.06
Prices/Earnings	-83.84	1.33	-8.20
Price/Sales	-72.65	1.92	7.01
Price/FCF	-48.83	12.31	-24.06
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	168.18	0.51	-0.19
ROA	398.42	0.09	-0.02
ROE	-0.05	0.21	341.80
ROIC	-0.02	0.14	785.36
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.23	0.21	9.55
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	< 0.005	10.00	241349.79
EPS QOQ	0.04	7.30	20329.63
FCF QOQ	0.41	2.79	578.95
Revenue QOQ	-0.06	2.36	3652.77
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	164.72	145.97	-11.38
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.50	0.37	-25.24
Quick Ratio	0.67	1.30	93.33
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	34.38	44.08	28.21
Cash	9.81	9.25	-5.66
Capex	-0.89	1.57	75.53
Free Cash Flow	-2.22	3.96	78.93
Revenue	7.60	25.45	234.74
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.37	1.68	23.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-17.62	1.37	-92.23
Naive Interpretation	Member

06 - Financial Health · Weak

Rating